CaaS Capital Management - aVenture Asset Manager Research
Location
New York City, NY, US
Founded
2019
CaaS Capital Management is a New York City-based global investment firm specializing in equity capital markets and liquidity provision. The firm actively participates in both private and public markets, focusing on Series B, Series C, Post-IPO Equity, and Private Equity rounds. CaaS Capital Management aims to assist businesses in achieving their capital-raising goals while adhering to meticulous risk controls and diversification strategies.
Notable portfolio companies include 2seventy bio, HotSpot Therapeutics, Rapid Micro Biosystems, Solid Biosciences, StrideBio, Umoja Biopharma, and Werewolf Therapeutics. The firm is a single-family office that emphasizes cultivating mutually beneficial relationships among stakeholders and effecting positive change through its investments. CaaS Capital Management leverages its extensive expertise to provide value-added services to its portfolio companies, ensuring sustainable growth and success.
CaaS Capital Management - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies8
Current Portfolio Count8
Top Investment Stages
Series B4 (66.7%)
Series C1 (16.7%)
Series D1 (16.7%)
Stage Mix
Series B 67%Series C 17%Series D 17%
Concentration shown as share of disclosed investments by stage.
